Simulations Plus, Inc. (NASDAQ:SLP) Receives $51.40 Average PT from Brokerages

Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) has been given an average recommendation of "Buy" by the seven analysts that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $51.40.

SLP has been the subject of several research analyst reports. StockNews.com lowered shares of Simulations Plus from a "hold" rating to a "sell" rating in a research note on Monday, November 4th. BTIG Research lowered their target price on Simulations Plus from $60.00 to $50.00 and set a "buy" rating on the stock in a research note on Thursday, October 24th. Stephens assumed coverage on Simulations Plus in a report on Friday. They issued an "overweight" rating and a $39.00 price objective for the company. William Blair reaffirmed an "outperform" rating on shares of Simulations Plus in a report on Wednesday, November 6th. Finally, KeyCorp started coverage on shares of Simulations Plus in a research note on Monday, July 29th. They issued an "overweight" rating and a $47.00 target price for the company.

Simulations Plus Price Performance

SLP stock traded down $0.48 during midday trading on Monday, reaching $28.29. The company had a trading volume of 176,294 shares, compared to its average volume of 134,811. The stock has a 50 day moving average price of $31.19 and a 200-day moving average price of $38.83. The company has a market capitalization of $567.78 million, a price-to-earnings ratio of 59.23 and a beta of 0.71. Simulations Plus has a 1-year low of $27.22 and a 1-year high of $51.22.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The firm had revenue of $18.70 million for the quarter, compared to the consensus estimate of $19.73 million. During the same quarter in the previous year, the company earned $0.18 EPS. The company's revenue for the quarter was up 19.9% on a year-over-year basis. As a group, research analysts anticipate that Simulations Plus will post 1.12 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction on Friday, November 1st. The shares were sold at an average price of $27.66, for a total transaction of $553,200.00. Following the completion of the transaction, the director now directly owns 3,462,584 shares of the company's stock, valued at approximately $95,775,073.44. This trade represents a 0.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Over the last ninety days, insiders have sold 60,750 shares of company stock worth $1,905,655. Company insiders own 20.90% of the company's stock.

Hedge Funds Weigh In On Simulations Plus

Several large investors have recently modified their holdings of the stock. Azzad Asset Management Inc. ADV grew its stake in shares of Simulations Plus by 3.6% during the second quarter. Azzad Asset Management Inc. ADV now owns 8,007 shares of the technology company's stock valued at $389,000 after buying an additional 280 shares during the last quarter. InTrack Investment Management Inc grew its position in Simulations Plus by 1.1% in the 2nd quarter. InTrack Investment Management Inc now owns 31,665 shares of the technology company's stock valued at $1,540,000 after acquiring an additional 330 shares during the last quarter. First Horizon Advisors Inc. increased its stake in Simulations Plus by 82.6% in the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company's stock worth $26,000 after purchasing an additional 370 shares during the period. Chatham Capital Group Inc. lifted its position in shares of Simulations Plus by 1.3% during the second quarter. Chatham Capital Group Inc. now owns 34,554 shares of the technology company's stock worth $1,680,000 after purchasing an additional 450 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Simulations Plus by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company's stock valued at $311,000 after purchasing an additional 456 shares during the period. Institutional investors own 78.08% of the company's stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.